[Federal Register Volume 82, Number 190 (Tuesday, October 3, 2017)]
[Notices]
[Pages 46058-46060]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-21122]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30 Day-17-1083]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled National Notifiable Diseases Surveillance 
System to the Office of Management and Budget (OMB) for review and 
approval. CDC previously published a ``Proposed Data Collection 
Submitted for Public Comment and Recommendations'' notice on December 
22, 2016 to obtain comments from the public and affected agencies. CDC 
received one comment related to the previous notice. This notice serves 
to allow an additional 30 days for public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:

[[Page 46059]]

    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to [email protected]. Direct written comments 
and/or suggestions regarding the items contained in this notice to the 
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th 
Street NW., Washington, DC 20503 or by fax to (202) 395-5806. Provide 
written comments within 30 days of notice publication.

Proposed Project

    Evaluation of the National Tobacco Prevention and Control Public 
Education Campaign (OMB Control Number 0920-1083, Expiration 09/30/
2017)--Revision--National Center for Chronic Disease Prevention and 
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention 
(CDC).

Background and Brief Description

    In 2012, HHS/CDC launched Phase 1 of the National Tobacco 
Prevention and Control Public Education Campaign (The Campaign). The 
primary objectives of The Campaign are to encourage smokers to quit 
smoking and to encourage nonsmokers to communicate with smokers about 
the dangers of smoking. To evaluate ``The Campaign,'' CDC obtained OMB 
approval for information collections beginning in 2012 (OMB Control 
Number 0920-0923). CDC conducted baseline and follow-up surveys with 
both smokers and nonsmokers.
    In 2013, CDC launched Phase 2 of ``The Campaign'' and conducted an 
additional survey with smokers and one additional survey with 
nonsmokers under OMB Control Number 0920-0923.
    CDC recently completed collecting the information needed to 
evaluate Phase 3 of ``The Campaign,'' which launched in early 2014. The 
evaluation of The Campaign in 2014 consisted of a longitudinal cohort 
using four waves of online surveys involving smokers and three waves 
involving nonsmokers to assess their awareness of and reactions to the 
2014 advertisements as related to The Campaign's objectives (see 
previously-approved information collection with OMB Control Number 
0920-0923, expired 3/31/2017).
    The final wave of this data collection effort also served as a pre-
campaign baseline for Phase 4 of the campaign in 2015. The CDC 
subsequently aired Phase 5 of the campaign in 2016. To evaluate Phases 
4 and 5, CDC fielded four additional waves of survey data collection. 
CDC fielded these data collections from September to November in 2015 
and March to June, June to August, and November to December of 2016 
(see previously approved information collection under OMB Control 
Number 0920-1083, expires 9/30/2017).
    CDC has scheduled to launch new media activities for Phases 6 and 7 
of ``The Campaign'' in early 2017 and early 2018, respectively. To 
support evaluation of ``The Campaign'' through Phases 6 and 7, CDC 
plans to field five new waves of information collection. CDC will field 
the surveys in English and Spanish and will occur during 2017 and 2018. 
Once enrolled in the first wave of data collection, researchers will 
re-contact all participants for follow-up at subsequent survey waves.
    The sample for the data collection will originate from two sources: 
(1) An online longitudinal cohort of smokers and nonsmokers, sampled 
randomly from postal mailing addresses in the United States (address-
based sample, or ABS); and (2) the existing GfK KnowledgePanel, an 
established long-term online panel of U.S. adults. The ABS-sourced 
longitudinal cohort will consist of smokers and nonsmokers who have not 
previously participated in any established online panels to reduce 
potential panel conditioning bias from previous participation. GfK will 
recruit the new cohort, utilizing similar recruitment methods that are 
used in the recruitment of KnowledgePanel. To support larger sample 
sizes that will allow for more in-depth subgroup analysis, which is a 
key objective for CDC, researchers will use the GfK KnowledgePanel in 
combination with the new ABS-sourced cohort. Researchers will conduct 
all online surveys, regardless of sample source, via the GfK 
KnowledgePanel Web portal for self-administered surveys.
    Researchers will collect information through Web surveys (self-
administered on computers in the respondent's home or in another 
convenient location). Researchers will collect information about 
smokers' and nonsmokers' awareness of and exposure to specific campaign 
advertisements; knowledge, attitudes, beliefs related to smoking and 
secondhand smoke; and other marketing exposure. The surveys will also 
measure behaviors related to smoking cessation (among the smokers in 
the sample) and behaviors related to nonsmokers' encouragement of 
smokers to quit smoking, recommendations of cessation services, and 
attitudes about other tobacco and nicotine products.
    It is important to evaluate ``The Campaign'' in a context that 
assesses the dynamic nature of tobacco product marketing and uptake of 
various tobacco products, particularly since these may affect 
successful cessation rates. Survey instruments may be updated to 
include new or revised items on relevant topics, including cigars, 
noncombustible tobacco products, and other emerging trends in tobacco 
use.
    Participation is voluntary and there are no costs to respondents 
other than their time. CDC estimates the total response burden at 
37,170 hours over two years between August 2017 and February 2019. 
Thus, CDC estimates the total annualized burden hours at 18,585 for the 
combined English and Spanish versions of each survey.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
         (Type of) respondents                  Form name            Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
General Population....................  Screening & Consent               23,750               1            5/60
                                         Questionnaire (English).

[[Page 46060]]

 
                                        Screening & Consent                1,250               1            5/60
                                         Questionnaire (Spanish).
Adults Smokers and Nonsmokers, ages 18- Smoker Survey (Wave A)             6,175               1           30/60
 54, in the United States.               (English).
                                        Smoker Survey (Wave A)               325               1           30/60
                                         (Spanish).
                                        Smoker Survey (Wave B)             3,800               1           30/60
                                         (English).
                                        Smoker Survey (Wave B)               200               1           30/60
                                         (Spanish).
                                        Smoker Survey (Wave C)             3,800               1           30/60
                                         (English).
                                        Smoker Survey (Wave C)               200               1           30/60
                                         (Spanish).
                                        Smoker Survey (Wave D)             3,800               1           30/60
                                         (English).
                                        Smoker Survey (Wave D)               200               1           30/60
                                         (Spanish).
                                        Smoker Survey (Wave E)             3,800               1           30/60
                                         (English).
                                        Smoker Survey (Wave E)               200               1           30/60
                                         (Spanish).
                                        Nonsmoker Survey (Wave             2,375               1           30/60
                                         A) (English).
                                        Nonsmoker Survey (Wave               125               1           30/60
                                         A) (Spanish).
                                        Nonsmoker Survey (Wave             1,900               1           30/60
                                         B) (English).
                                        Nonsmoker Survey (Wave               100               1           30/60
                                         B) (Spanish).
                                        Nonsmoker Survey (Wave             1,900               1           30/60
                                         C) (English).
                                        Nonsmoker Survey (Wave               100               1           30/60
                                         C) (Spanish).
                                        Nonsmoker Survey (Wave             1,900               1           30/60
                                         D) (English).
                                        Nonsmoker Survey (Wave               100               1           30/60
                                         D) (Spanish).
                                        Nonsmoker Survey (Wave             1,900               1           30/60
                                         E) (English).
                                        Nonsmoker Survey (Wave               100               1           30/60
                                         E) (Spanish).
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-21122 Filed 10-2-17; 8:45 am]
 BILLING CODE 4163-18-P